Trials / Completed
CompletedNCT05580783
Iron Absorption and Variations of Iron Status, Hepcidin, Inflammation and Sex Hormones During the Menstrual Cycle
Iron Absorption and Variations of Iron Status Parameters, Hepcidin, Inflammatory Markers and Sex Hormones During the Menstrual Cycle
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Isabelle Herter-Aeberli · Academic / Other
- Sex
- Female
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Iron supplementation is the first line of treatment of iron deficiency in most women, but we do not know when the best time is to supplement in the context of the menstrual cycle. With this study, we aim to measure and compare iron status, hepcidin, inflammatory markers, hormones estrogen and progesterone and changes in iron absorption at various points throughout the menstrual cycle, with a long-term view to determine best time for iron supplementation in relation to the menstrual cycle.
Detailed description
To date, very few studies have assessed iron absorption in relation to a woman's menstrual cycle. Although oral iron supplementation is considered the first line of treatment for iron deficiency in most women, there is no knowledge on the relationship between this intervention in the context of the menstrual cycle, and more specifically there is no knowledge on its potential implications for the most appropriate timing of iron supplementation. A better understanding of iron absorption during the menstrual cycle as well as kinetics of key parameters could allow the design of adapted and/or new interventions (e.g., timing of iron supplementation in relation to different phases of the menstrual cycle) to mitigate iron deficiency in menstruating women and can inform programs aimed at addressing iron deficiency
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Test meal labelled with 54Fe | Each participant will receive 2 test meals containing 4mg each of isotopic tracer 54Fe |
| OTHER | Test meal labelled with 57Fe | Each participant will receive 2 test meals containing 4mg each of isotopic tracer 57Fe |
| OTHER | Test meal labelled with 58Fe | Each participant will receive 2 test meals containing 4mg each of isotopic tracer 58Fe |
Timeline
- Start date
- 2022-11-05
- Primary completion
- 2023-01-06
- Completion
- 2023-05-15
- First posted
- 2022-10-14
- Last updated
- 2023-11-22
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05580783. Inclusion in this directory is not an endorsement.